Alternatives
Alternatives to Promacta 12.5 mg powder for oral suspension
1 other presentations of Eltrombopag 12.5 mg powder for oral suspension
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Eltrombopag), strength (12.5 mg) and dosage form (powder for oral suspension) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Promacta 12.5 mg powder for oral suspensionThis pageOral | Novartis Pharmaceuticals | US FDA | 1 carton | Store at room temperature between 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F). Each kit (NDC 0078-0697-61) contains 30 packets: NDC 0078-0697-19 Store at room temperature between 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F). | On request | — | Available on request |
| Eltrombopag 12.5 mg powder for oral suspensionOral | — | US FDA | 1 carton | Store at room temperature between 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F). Following reconstitution, the product should be administered immediately but may be stored for a maximum period of 30 minutes between 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F). | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Promacta 12.5 mg powder for oral suspensionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.